The AWARD-7 trial, which is notable for its exclusive focus on patients with moderate-to-severe chronic kidney disease, demonstrated that dulaglutide users, particularly those simultaneously using ACE inhibitors or angiotensin receptor blockers, exhibited a substantially less eGFR decline compared to insulin glargine users
In Phase 3 trials, maximal dose retatrutide showed 29% placebo-adjusted weight loss at 68 weeks , with an expected launch in 2027/28
[6] [16] For liraglutide (Saxenda), criteria include a BMI of 35 kg/m or above (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity
doi: 10.1084/jem.20061287 76 WangYWangWShenCWangYJiaoMYuWet al
Moving from overweight to normal weight restores energy, eliminates the subtle joint stress that accompanies excess weight, and often resolves early metabolic dysfunction before it progresses to disease
Drinking enough water helps keep your bile thin and flowing freely, reducing the chance that it will thicken and form stones
